GlassScriptPhysician profile
Bryan K Krepps
NPI 1073693669
$2,191.25
in general payments reported to CMS, 2019-2025
31 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $660 · 2020: $422 · 2021: $354 · 2022: $353 · 2023: $166 · 2024: $236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $375 · Education: $26.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $375.16 |
| Education | $26.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $521.57 | 2019-2024 | |
| Astellas Pharma US INC | $464.88 | 2019-2024 | Veozah |
| Coopersurgical, INC. | $208.60 | 2019-2021 | |
| Shield Therapeutics INC | $114.39 | 2023-2024 | Accrufer |
| Amag Pharmaceuticals, INC. | $67.90 | 2019 | |
| Organon LLC | $65.26 | 2022-2024 | Nexplanon |
| Amgen INC. | $59.82 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $56.94 | 2023-2024 | Myfembree, Gemtesa |
| Exeltis, USA INC. | $49.73 | 2020-2022 | |
| Evofem Biosciences, INC. | $48.62 | 2020-2021 | |
| Medline Industries LP | $47.62 | 2019 | |
| Hologic Sales and Service, LLC | $40.80 | 2022-2024 | Aptima |
| Therapeuticsmd, INC. | $39.95 | 2020 | |
| Daiichi Sankyo INC. | $39.38 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.54 | 2019-2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $35.74 | 2023 | |
| Myovant Sciences INC. | $27.10 | 2021-2022 | |
| Millicent US INC | $26.70 | 2024 | |
| Agile Therapeutics, INC. | $25.94 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $25.65 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $25.51 | 2019-2021 | |
| Duchesnay USA Incorporated | $24.59 | 2019 | |
| Roche Diagnostics Corporation | $22.41 | 2019 | |
| Ascend Therapeutics US, LLC | $18.00 | 2021 | |
| Pfizer INC. | $16.85 | 2024 | |
| Urovant Sciences INC | $15.01 | 2021 | |
| Avion Pharmaceuticals | $13.96 | 2021 | |
| Optumhealth Care Solutions, LLC | $13.85 | 2024 | Vivify Health Care Team Portal 001, Eitan Medical |
| Glaxosmithkline, LLC. | $13.16 | 2021 | |
| Gilead Sciences, INC. | $12.16 | 2019 | |
| Lupin INC. | $11.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Krepps listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.